Venous congestion

Venous congestion refers to the pooling and impaired return of blood within the venous system, most often manifesting in the lower extremities or pelvis. It leads to increased venous pressure, reduced tissue oxygenation, edema, and can trigger inflammatory and neurohormonal activation in endothelial cells, contributing to vascular and organ dysfunction. Venous congestion is secondary to conditions such as chronic venous insufficiency, heart failure, or vein valve dysfunction, and is not a discrete molecular entity. Current treatments target the underlying circulatory disorder, not venous congestion as a direct pharmacological target[2][4][5][7]. Key Notes: - This entry is incorrect as a therapeutic target because "venous congestion" is a syndrome, not a molecule, gene, protein, or receptor. - If structure-level, molecular, or receptor information is needed, a specific protein within the congestion-related pathway (e.g., Endothelin-1 receptor, TNF-alpha) should be specified instead[2][4]. For structured database purposes, do not include "Venous congestion" as a pharmacological target. Instead, consider molecular mediators or receptors implicated in its pathophysiology.

Other names

Chronic venous congestionVenous stasisVenous poolingPelvic venous congestion syndrome (formation-specific)Venous insufficiency

Mechanisms involve relief of fluid overload, venous tone modulation, or improvement of venous return—not interaction with a molecular target.